{
  "meta": {
    "title": "27_Opioid_Antagonists",
    "url": "https://brainandscalpel.vercel.app/27-opioid-antagonists-fbe07913.html",
    "scrapedAt": "2025-11-30T12:34:15.478Z"
  },
  "questions": [
    {
      "text": "Which of the following is a pure opioid antagonist?",
      "choices": [
        {
          "id": 1,
          "text": "Naloxone"
        },
        {
          "id": 2,
          "text": "Naltrexone"
        },
        {
          "id": 3,
          "text": "Nalorphine"
        },
        {
          "id": 4,
          "text": "Both a and b"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Both naloxone and naltrexone are <strong>pure</strong> opioid <strong>antagonists</strong>.&nbsp;</p>\n<p><strong>Nalorphine</strong> is an <strong>agonist-antagonist</strong>. It has antagonistic activity at the mu receptor and additional agonistic activity at the kappa receptor.</p>\n<p><strong>Note</strong>: Nalmefene is sometimes classified as a pure antagonist but it has additional kappa receptor partial agonist activity.</p><hr><h3>Related Pearl: Classification of opioids based on their action on opioid receptors</h3><div class=\"page\" title=\"Page 569\">\n<table><colgroup><col /><col /><col /><col /><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Generic Name</strong></p>\n</div>\n</div>\n</td>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Receptor Effects&nbsp;</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>&micro;</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>&delta;</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>&kappa;</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Morphine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Methadone</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Meperidine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Fentanyl</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Sufentanil</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Codeine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&plusmn;</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Pentazocine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&plusmn;</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Nalbuphine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>-</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>++</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Buprenorphine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&plusmn;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>-</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>-</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Butorphanol</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&plusmn;</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"page\" title=\"Page 569\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++, ++, +, strong agonist; &plusmn;, partial or weak agonist; -, antagonist.</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Pure opioid antagonists</h3><p><strong>Naloxone</strong>: short-acting opioid antagonist with duration of action of 1-2 hours. Used in opioid overdose and respiratory depression in newborns due to perinatal opioid use.</p>\n<p><strong>Naltrexone</strong>: long-acting opioid antagonist with effects lasting till 48 hours. Used for prevention of relapse in opioid addiction treatment. It is associated with hepatotoxicity. It does not suppress craving in opioid addiction but suppresses craving in chronic alcoholics.</p>\n<p><strong>Nalmefene</strong>: long-acting opioid antagonist with a half-life of 8-10 hours administered intravenously. Used in opioid overdose like naloxone.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6855",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is incorrect about opioid antagonists?",
      "choices": [
        {
          "id": 1,
          "text": "Naloxone is a short acting drug"
        },
        {
          "id": 2,
          "text": "Naltrexone lowers craving in alcoholics"
        },
        {
          "id": 3,
          "text": "Nalmefene can be used for treatment of opioid overdose"
        },
        {
          "id": 4,
          "text": "Nalmefene is shorter acting than naloxone"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Nalmefene</strong> is <strong>longer-acting</strong> (not shorter-acting) than naloxone.</p><hr><h3>Related Pearl: Pure opioid antagonists</h3><p><strong>Naloxone</strong>: short-acting opioid antagonist with duration of action of 1-2 hours. Used in opioid overdose and respiratory depression in newborns due to perinatal opioid use.</p>\n<p><strong>Naltrexone</strong>: long-acting opioid antagonist with effects lasting till 48 hours. Used for prevention of relapse in opioid addiction treatment. It is associated with hepatotoxicity. It does not suppress craving in opioid addiction but suppresses craving in chronic alcoholics.</p>\n<p><strong>Nalmefene</strong>: long-acting opioid antagonist with a half-life of 8-10 hours administered intravenously. Used in opioid overdose like naloxone.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6876",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is false about naltrexone?",
      "choices": [
        {
          "id": 1,
          "text": "Is orally active"
        },
        {
          "id": 2,
          "text": "Is used in the treatment of alcohol dependence"
        },
        {
          "id": 3,
          "text": "Is less potent than naloxone"
        },
        {
          "id": 4,
          "text": "Is a pure opioid antagonist"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Naltrexone is <strong>more potent</strong> than naloxone.</p>\n<p>Naltrexone is a pure opioid antagonist which is orally active.</p>\n<p>Alcohol craving is reduced by naltrexone. It is also approved for the prevention of relapse in opioid addiction treatment.</p><hr><h3>Related Pearl: Pure opioid antagonists</h3><p><strong>Naloxone</strong>: short-acting opioid antagonist with duration of action of 1-2 hours. Used in opioid overdose and respiratory depression in newborns due to perinatal opioid use.</p>\n<p><strong>Naltrexone</strong>: long-acting opioid antagonist with effects lasting till 48 hours. Used for prevention of relapse in opioid addiction treatment. It is associated with hepatotoxicity. It does not suppress craving in opioid addiction but suppresses craving in chronic alcoholics.</p>\n<p><strong>Nalmefene</strong>: long-acting opioid antagonist with a half-life of 8-10 hours administered intravenously. Used in opioid overdose like naloxone.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6863",
      "difficulty": "easy"
    },
    {
      "text": "A patient is on chronic opioid therapy for pain management. He would not develop tolerance against which of the following actions of opioids?",
      "choices": [
        {
          "id": 1,
          "text": "Miosis"
        },
        {
          "id": 2,
          "text": "Analgesia"
        },
        {
          "id": 3,
          "text": "Euphoria"
        },
        {
          "id": 4,
          "text": "Nausea and vomiting"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Tolerance is developed to all the above actions of opioids<strong> except</strong> for<strong> miosis</strong>.</p>\n<p><strong>Exceptions</strong> to opioid tolerance (<strong>3C</strong>'s):</p>\n<ul>\n<li><strong>C</strong>onstricted pupil (miosis)</li>\n<li><strong>C</strong>onstipation</li>\n<li><strong>C</strong>onvulsions</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6829",
      "difficulty": "easy"
    },
    {
      "text": "An elderly man, who is on chronic morphine therapy for pain relief, visits your clinic with complaints of not passing stools for the last 4 days. Which of the following drugs is best suited to treat his condition?",
      "choices": [
        {
          "id": 1,
          "text": "Naltrexone"
        },
        {
          "id": 2,
          "text": "Methylnaltrexone"
        },
        {
          "id": 3,
          "text": "Dextromethorphan"
        },
        {
          "id": 4,
          "text": "Nalmefene"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical picture points towards <strong>opioid-induced constipation</strong>. <strong>M</strong><strong>ethylnaltrexone,&nbsp;</strong>an opioid antagonist with <strong>predominant peripheral action</strong> is best suited for treating opioid-induced constipation.</p>\n<p>Methylnaltrexone is a <strong>peripheral</strong> <strong>&micro; receptor antagonist.&nbsp;</strong>It was introduced in the treatment of opioid-induced constipation&nbsp;refractory to other measures.</p>\n<p>It is a quaternary ammonium compound and hence <strong>cannot cross </strong>the<strong> blood-brain barrier. </strong>It can reverse the effects mediated by peripheral opioid receptors and spares CNS effects like analgesia.</p>\n<p>The <strong>peripherally acting opioid antagonists</strong> include:</p>\n<ul>\n<li>Methylnaltrexone</li>\n<li>Naloxegol</li>\n<li>Naldemedine</li>\n<li>Alvimopan</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6870",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not an antagonist at Âµ receptor?",
      "choices": [
        {
          "id": 1,
          "text": "Naltrindole"
        },
        {
          "id": 2,
          "text": "Naloxone"
        },
        {
          "id": 3,
          "text": "Nalbuphine"
        },
        {
          "id": 4,
          "text": "Naltrexone"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Naltrindole</strong> is a new <strong>non-peptide</strong> drug which has a <strong>selective antagonistic </strong>activity on the <strong>&delta; receptor. </strong>This drug is still in the trial phase and is not yet in use.</p>\n<p>Option B: Naloxone is considered a pure opioid receptor antagonist but at high doses, it is found to have partial agonistic activity on the &mu;- and &kappa;-opioid receptors.</p>\n<p>Option C: Nalbuphine is an <strong>agonist-antagonist</strong> opioid which acts as an antagonist at the &mu; receptor and an agonist at the &kappa; receptor.</p>\n<p>Option D: Naltrexone is a &mu;-, &delta;- and &kappa;-opioid receptor antagonist.</p><hr><h3>Related Pearl: Classification of opioids based on their action on opioid receptors</h3><div class=\"page\" title=\"Page 569\">\n<table><colgroup><col /><col /><col /><col /><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td colspan=\"1\" rowspan=\"2\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Generic Name</strong></p>\n</div>\n</div>\n</td>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Receptor Effects&nbsp;</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>&micro;</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>&delta;</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>&kappa;</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Morphine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Methadone</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Meperidine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Fentanyl</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Sufentanil</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Codeine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&plusmn;</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Pentazocine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&plusmn;</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Nalbuphine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>-</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>++</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Buprenorphine</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&plusmn;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>-</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>-</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Butorphanol</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&plusmn;</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div class=\"page\" title=\"Page 569\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>+++, ++, +, strong agonist; &plusmn;, partial or weak agonist; -, antagonist.</p>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0711",
      "difficulty": "medium"
    },
    {
      "text": "A 27-year-old man presented to the casualty with slurred speech and shallow breathing. On examination, you find he has bradycardia, hypotension, and pin-point pupils. Which drug will you choose to treat him?",
      "choices": [
        {
          "id": 1,
          "text": "Nalorphine"
        },
        {
          "id": 2,
          "text": "Naltrexone"
        },
        {
          "id": 3,
          "text": "Naloxone"
        },
        {
          "id": 4,
          "text": "Nalmefene"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical features are suggestive of&nbsp;<strong>opioid overdose</strong>. <strong>Naloxone</strong>&nbsp;is the drug of choice for opioid overdose.</p>\n<p>Opioid overdose symptoms:</p>\n<ul>\n<li>Triad of coma, respiratory depression, and pinpoint pupils (miosis)</li>\n<li>Hypotension, bradycardia</li>\n<li>Shallow breathing</li>\n<li>Hypothermia</li>\n</ul>\n<p>Naloxone is also used for reversing neonatal asphyxia due to opioid usage in labor.&nbsp;Naloxone is a pure opioid antagonist which reverses all effects<strong> except sedation</strong>.</p>\n<p><strong>Note</strong>: Naloxone is contraindicated in infants born to mothers with opiate addiction as it may precipitate acute neonatal withdrawal with <strong>seizures</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6852",
      "difficulty": "easy"
    },
    {
      "text": "A college student who is addicted to intravenous heroin abruptly stopped abusing the drug during exams. Which of the following would you not expect as a part of withdrawal?",
      "choices": [
        {
          "id": 1,
          "text": "Lacrimation"
        },
        {
          "id": 2,
          "text": "Constipation"
        },
        {
          "id": 3,
          "text": "Increased salivation and running nose"
        },
        {
          "id": 4,
          "text": "Yawning"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Diarrhea</strong>&nbsp;(not constipation) <strong>is seen&nbsp;</strong>in opioid withdrawal.</p>\n<p><strong>O</strong>pioid<strong>&nbsp;</strong>withdrawal symptoms (mnemonic- O MY WITHDRAWALS):</p>\n<ul>\n<li><strong>My</strong>driasis</li>\n<li><strong>Y</strong>awning</li>\n<li><strong>W</strong>eakness</li>\n<li><strong>I</strong>nsomnia, irritability</li>\n<li><strong>T</strong>remors, <strong>t</strong>achycardia</li>\n<li><strong>H</strong>ypertension, <strong>h</strong>yperactive</li>\n<li><strong>D</strong>iarrhea</li>\n<li><strong>R</strong>hinorrhoea</li>\n<li><strong>A</strong>pnoeic attacks</li>\n<li><strong>W</strong>eight loss</li>\n<li><strong>A</strong>nxiety</li>\n<li><strong>L</strong>acrimation</li>\n<li><strong>S</strong>weating</li>\n</ul><hr><h3>Related Pearl: Substances of abuse</h3><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Substance</strong></span></div>\n</td>\n<td>\n<div><span><strong>Withdrawal symptoms</strong></span></div>\n</td>\n<td>\n<div><span><strong>Intoxication features</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Alcohol</strong></span></div>\n</td>\n<td>\n<div><span>Tremors, delirium, seizures</span></div>\n</td>\n<td>\n<div><span>Blackouts, nystagmus and slurring of speech</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>BZD</strong></span></div>\n</td>\n<td>\n<div><span>Tremors,&nbsp;insomnia, anxiety</span></div>\n</td>\n<td>\n<div><span>Lethargy and drowsiness.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Opioid/ Heroin</strong></span></div>\n</td>\n<td>\n<div><span>Diarrhea,&nbsp;yawning, mydriasis,&nbsp;lacrimation, piloerection, cold turkey phenomenon</span></div>\n</td>\n<td>\n<div><span>Euphoria, depressed mental status, miosis, respiratory depression, constipation.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Nicotine/ Tobacco</strong></span></div>\n</td>\n<td>\n<div><span>Increased appetite</span></div>\n</td>\n<td>\n<div><span>Shows a biphasic pattern.&nbsp;</span></div>\n<div><span>Early stimulatory symptoms of vomiting, hypertension and tachycardia.&nbsp;</span><span>Later depressive symptoms of hypotension and bradycardia.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Cannabis</strong></span></div>\n</td>\n<td>\n<div><span>Irritability, sweating, tremors, decreased appetite</span></div>\n</td>\n<td>\n<div><span>Increased appetite, euphoria, conjunctival injection, dry mouth,&nbsp;</span><span>panic,&nbsp;</span><span>synesthesia, impaired time perception, amotivational&nbsp;syndrome, run amok and&nbsp;</span><span>flashbacks.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Amphetamine</strong></span></div>\n</td>\n<td>\n<div><span>Depressed mood, suicidal thoughts, unpleasant dreams</span></div>\n</td>\n<td>\n<div>\n<div><span>Acute:&nbsp;</span><span>Sympathetic&nbsp;</span><span>overactivity, paranoid hallucinatory syndrome, violent behavior, psychosis and diaphoresis.</span></div>\n</div>\n<div><span>Chronic: Runs &amp; crashes, choreiform movements, tooth decay. Can resemble schizophrenia.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Cocaine</strong></span></div>\n</td>\n<td>\n<div><span>Depressed mood, suicidal thoughts</span></div>\n</td>\n<td>\n<div><span>Acute: Sympathetic overactivity, agitation, euphoria, chest pain, seizures and mydriasis</span></div>\n<div><span>Chronic: Cocaine psychosis (Magnan sign) and black pigmentation of the tongue.</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>LSD/ Haluccinogen</strong></span></div>\n</td>\n<td>\n<div><span>Nothing significant</span></div>\n</td>\n<td>\n<div>\n<div><span>Synesthesia, brisk tendon reflex, t</span>achycardia, hypertension, panic, ataxia, visual hallucinations, euphoria and dysphoria.</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span><strong>Phencyclidine (PCP)</strong></span></div>\n</td>\n<td>\n<div><span>Nothing significant&nbsp;</span></div>\n</td>\n<td>\n<div>Tachycardia, hypertension, ataxia, hallucinations, violent behavior, dissociation, amnesia and nystagmus.</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1477",
      "difficulty": "easy"
    },
    {
      "text": "An elderly woman who was dependent on morphine for her palliative care recently got switched to another opioid medication. A few days later she started developing withdrawal symptoms. Which of the following opioids would have been prescribed to her?",
      "choices": [
        {
          "id": 1,
          "text": "Pethidine"
        },
        {
          "id": 2,
          "text": "Pentazocine"
        },
        {
          "id": 3,
          "text": "Morphine"
        },
        {
          "id": 4,
          "text": "Methadone"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Pentazocine</strong> can precipitate <strong>withdrawal symptoms</strong> in opioid-dependent patients.</p>\n<p>It acts as a <strong>weak antagonist</strong> or <strong>partial agonist</strong> at<strong> mu</strong>-opioid receptors which may precipitate withdrawal symptoms.</p>\n<p>Options A, C, and D: Pethidine, morphine, and methadone are <strong>pure agonists </strong>at<strong> mu-</strong>receptors and <strong>do not </strong>precipitate withdrawal symptoms.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1473",
      "difficulty": "medium"
    },
    {
      "text": "A 33-year-old man with a history of heroin addiction is referred to a rehabilitation center. Which of the following would you use as a substitute drug for maintenance therapy?",
      "choices": [
        {
          "id": 1,
          "text": "Methylmorphine"
        },
        {
          "id": 2,
          "text": "Methadone"
        },
        {
          "id": 3,
          "text": "Meperidine"
        },
        {
          "id": 4,
          "text": "Methylphenidate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Methadone</strong>&nbsp;is used as a substitute drug for the <strong>maintenance</strong>&nbsp;therapy of opioid (heroin) dependence. This is because of its <strong>good oral bioavailability</strong> and <strong>long half-life</strong>.&nbsp;</p>\n<p>Methadone is substituted for opioids during detoxification<strong> to avoid withdrawal</strong> symptoms.&nbsp;Once stabilized, the dose is gradually reduced and the drug is stopped slowly over days.&nbsp;</p>\n<p>Due to its long half-life and accumulation in tissues, discontinuing the drug still results in low concentrations of the drug in plasma resulting in protracted withdrawal symptoms.</p>\n<p>Maintainance therapy for opioid dependence:</p>\n<ul>\n<li>Long-acting opioid agonist - a safer substitute like <strong>methadone</strong> is given in a supervised manner to <strong>prevent&nbsp;withdrawal</strong> symptoms</li>\n<li>Partial agonist -&nbsp;<strong>buprenorphine</strong> can also be used</li>\n<li><strong>Clonidine, lofexidine</strong> - alpha-2 agonists act as sympatholytic and <strong>reduce the withdrawal</strong> symptoms</li>\n<li><strong>LAAM</strong>(L-Alpha-Acetyl-Methadol) - opioid agonist which <strong>reduces craving</strong></li>\n<li><strong>Naltrexone -</strong>&nbsp;is an opioid antagonist used in&nbsp;maintenance therapy to&nbsp;<strong>prevent relapses</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6849",
      "difficulty": "easy"
    },
    {
      "text": "A physician prescribes naltrexone to a patient undergoing treatment for opioid addiction. What is the function of this drug in opioid addiction?",
      "choices": [
        {
          "id": 1,
          "text": "Prevention of relapse"
        },
        {
          "id": 2,
          "text": "Treatment of withdrawal"
        },
        {
          "id": 3,
          "text": "Treatment of overdose"
        },
        {
          "id": 4,
          "text": "Prevention of withdrawal"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Naltrexone is used for the<strong> prevention of relapse</strong>&nbsp;in opioid addiction.</p>\n<p>It is given only after initial opioid detoxification.&nbsp;The patient should be opioid-free for 7-10 days and have a negative naloxone challenge (no withdrawal after naloxone administration).</p>\n<p>Naltrexone is a pure opioid antagonist which is more potent than naloxone. It is <strong>orally active</strong> and has a <strong>long duration of action</strong> which makes it suitable for opioid blockade therapy in post-addicts.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6866",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is incorrect about the use of naltrexone in the treatment of opioid addiction?",
      "choices": [
        {
          "id": 1,
          "text": "Discontinuation of naltrexone does not cause withdrawal symptoms"
        },
        {
          "id": 2,
          "text": "It satisfies craving in opioid addicts"
        },
        {
          "id": 3,
          "text": "It blocks the effects of opioids if they are used"
        },
        {
          "id": 4,
          "text": "It is administered only when the patient has completed detoxification from opioids"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Naltrexone <strong>does not satisfy</strong> the <strong>craving</strong> of opioid addicts. It&nbsp;is an opioid <strong>antagonist</strong> with a high affinity for&nbsp;<strong>&mu;</strong> opioid receptors.<strong>&nbsp;</strong></p>\n<p>Naltrexone does not suppress craving in opioid addiction but it suppresses craving in chronic alcoholics.</p>\n<p>Opioid agonists such as<strong> methadone </strong>and<strong> buprenorphine suppress craving</strong> and <strong>withdrawal </strong>symptoms and are therefore used in the first stage of detoxification in opioid addiction.</p>\n<p>Option A: Discontinuation of naltrexone ingestion has <strong>no negative physical consequences</strong>, as opposed to discontinuation of agonist maintenance therapies, which results in the emergence of opioid withdrawal symptoms. This is a major reason for noncompliance and treatment failure.</p>\n<p>Option C: It <strong>blocks </strong>the <strong>effects of opioids&nbsp;</strong>and prevents the user from experiencing subjective symptoms of opioid intoxication such as euphoria on subsequent use. As the user does not experience these symptoms, he <strong>does not</strong> <strong>develop</strong> <strong>a craving</strong> for the substance. Thus, naltrexone <strong>prevents relapse.</strong></p>\n<p>Option D:&nbsp;It is only administered when the patient has completed a medically supervised detoxification from opioids because it can cause immediate withdrawal symptoms.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6871",
      "difficulty": "medium"
    },
    {
      "text": "You are treating a 31-year-old man with heroin dependence. Which of the following drugs would you not prescribe to him?",
      "choices": [
        {
          "id": 1,
          "text": "Disulfiram"
        },
        {
          "id": 2,
          "text": "Buprenorphine"
        },
        {
          "id": 3,
          "text": "Clonidine"
        },
        {
          "id": 4,
          "text": "Lofexidine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Disulfiram&nbsp;<strong>cannot</strong> be used to treat heroin dependence.</p>\n<p>It is an aldehyde dehydrogenase inhibitor used in the<strong> maintenance </strong>therapy of <strong>alcohol abstinence</strong>.</p>\n<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p>Maintainance therapy for opioid dependence:</p>\n<ul>\n<li>Long-acting opioid agonist - a safer substitute like&nbsp;<strong>methadone</strong>&nbsp;is given in a supervised manner to&nbsp;<strong>prevent&nbsp;withdrawal</strong>&nbsp;symptoms</li>\n<li>Partial agonist -&nbsp;<strong>buprenorphine</strong>&nbsp;can also be used</li>\n<li><strong>Clonidine, lofexidine</strong>&nbsp;- alpha-2 agonists act as sympatholytic and&nbsp;<strong>reduce the withdrawal</strong>&nbsp;symptoms</li>\n<li><strong>LAAM</strong>(L-Alpha-Acetyl-Methadol) - opioid agonist which&nbsp;<strong>reduces craving</strong></li>\n<li><strong>Naltrexone -</strong>&nbsp;is an opioid antagonist used in&nbsp;maintenance therapy to&nbsp;<strong>prevent relapses</strong></li>\n</ul>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6874",
      "difficulty": "medium"
    }
  ]
}